Market Place
Sourcing Support
BioNTech To Present Q4 2025 Financials And Corporate Update
24 Feb 2026 //
GLOBENEWSWIRE
BioNTech Sues Moderna For Patent Infringement Over COVID Shot
20 Feb 2026 //
REUTERS
Ryvu Therapeutics Supports BioNTech Clinical Trials in Poland
03 Sep 2025 //
CONTRACTPHARMA
BioNTech appoints Ramón Zapata as CFO to Management Board
05 May 2025 //
GLOBENEWSWIRE
BioNTech says Novartis executive Zapata to become CFO
05 May 2025 //
REUTERS
Tempus Announces Real World Data Collaboration with BioNTech
04 Sep 2024 //
BUSINESSWIRE
Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026
01 Aug 2024 //
REUTERS
BioNTech Reports Positive Phase 2 Results For BNT111 In Melanoma
30 Jul 2024 //
GLOBENEWSWIRE
BioNTech signs 3D printing deal to develop oral RNA drugs
24 Jul 2024 //
ENDPTS
BioNTech To Report Q2 2024 Results And Corporate Update August 5
22 Jul 2024 //
GLOBENEWSWIRE
CureVac Updates On Patent Litigation Trial Dates Against Pfizer/BioNTech
11 Jul 2024 //
ACCESSWIRE
Lyra to lay off 75% of its workers; Dupixent nears COPD decision
21 May 2024 //
ENDPTS
NightHawk becomes pure-play CDMO; Lonza to make liver cancer drug
14 Dec 2023 //
ENDPTS
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
28 Dec 2022 //
PRESS RELEASE
BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate
26 Dec 2022 //
EXPRESSPHARMA
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
23 Dec 2022 //
PRESS RELEASE
BioNTech and Fosun Pharma Announce Full Regulatory Approval
23 Dec 2022 //
PRESS RELEASE
BioNTech begins phase 1 trial for malaria vaccine
22 Dec 2022 //
PHARMAFILE
BioNTech gets ready to ship first mobile factory to Rwanda
22 Dec 2022 //
FIERCEPHARMA
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination
22 Dec 2022 //
PRESS RELEASE
BioNTech sends mRNA Covid-19 vaccines to China for expats
22 Dec 2022 //
ENDPTS
Update on First BioNTainer for African-based mRNA Manufacturing Facility
21 Dec 2022 //
PRESS RELEASE
AI tools are finally changing the biopharma landscape
21 Dec 2022 //
FIERCEPHARMA
What`s next for the COVID-19 vaccine game and its star players?
21 Dec 2022 //
FIERCEPHARMA
Update on First BioNTainer for African-based mRNA Manufacturing Facility
21 Dec 2022 //
PRESS RELEASE
BioNTech Starts Ph1 Trial for Prophylactic Herpes Simplex Virus-2 BNT163
21 Dec 2022 //
GLOBENEWSWIRE
Update on First BioNTainer for African-based mRNA Manufacturing Facility
21 Dec 2022 //
GLOBENEWSWIRE
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccinatio
21 Dec 2022 //
GLOBENEWSWIRE
BioNTech Announces Plans for Trial in Taiwan for mRNA Cancer Immunotherapies
16 Dec 2022 //
PRESS RELEASE
Scheduling for COVID-19 Dose for Children Available at Bartell Drugs locations
15 Dec 2022 //
BUSINESSWIRE
Lawmakers press Pfizer on fair commercial price for Comirnaty
14 Dec 2022 //
FIERCEPHARMA
US FDA grants fast track status for Pfizer-BioNTech’s combination vaccine
12 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
Canada authorizes first bivalent booster shot for 5 to 11 year-olds
10 Dec 2022 //
REUTERS
Pfizer & BioNTech Receive FDA Fast Track Designation for mRNA-Based Vaccine
09 Dec 2022 //
GLOBENEWSWIRE
U.S. CDC expands use of bivalent COVID vaccines for kids as young as 6 months
09 Dec 2022 //
REUTERS
U.S. FDA authorizes bivalent COVID shots for kids as young as 6 months old
09 Dec 2022 //
REUTERS
Pfizer & BioNTech Receive U.S. FDA EUA for Omicron BA.4/BA.5 Bivalent COVID-19
08 Dec 2022 //
GLOBENEWSWIRE
Britain`s health regulator backs COVID vaccine for infants from six months
07 Dec 2022 //
REUTERS
Pfizer, BioNTech fight Moderna with patent countersuit
06 Dec 2022 //
FIERCEPHARMA
Pfizer`s expansion continues with $750M investment in Michigan
06 Dec 2022 //
FIERCEPHARMA
Pfizer applies for FDA authorization for Omicron-retooled vaccine kids under 5
06 Dec 2022 //
REUTERS
Pfizer & BioNTech Submit Application to FDA for EUA of Omicron COVID-19 Vaccine
05 Dec 2022 //
PRESS RELEASE
Texas biotech’s COVID booster takes on competitors in phase 3
02 Dec 2022 //
FIERCEBIOTECH
BioNTech bets on difficult STING field via small molecule pact with biotech
30 Nov 2022 //
ENDPTS
BioNTech adds STING to oncology portfolio in €40M Ryvu deal
30 Nov 2022 //
FIERCEBIOTECH
BioNTech and Ryvu Enter into Global Collaboration Small Molecule Candidates
29 Nov 2022 //
GLOBENEWSWIRE
Germany working to ensure continued cooperation between BioNTech
28 Nov 2022 //
REUTERS
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent
18 Nov 2022 //
GLOBENEWSWIRE
Pfizer, BioNTech start study testing next COVID-19 vaccine
18 Nov 2022 //
BIOPHARMADIVE
Seeking protection, Pfizer & BioNTech move T-cell enhancing vaccine into clinic
17 Nov 2022 //
FIERCEBIOTECH
German panel recommends COVID shot only for at-risk youngsters
17 Nov 2022 //
REUTERS
Pfizer and BioNTech initiate Phase I trial of Covid-19 vaccine candidate
17 Nov 2022 //
CLINICALTRIALSARENA
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy
16 Nov 2022 //
GLOBENEWSWIRE
China Mulls Emergency Approval of BioNTech Vaccine for Foreigners, COO Says
14 Nov 2022 //
BLOOMBERG
BioNTech Acquires Novartis Mfg. Site in Singapore for mRNA Production
14 Nov 2022 //
CONTRACTPHARMA
BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site
14 Nov 2022 //
PRESS RELEASE
BioNTech and Fosun Pharma Receive EUA for Omicron-BA.4/BA.5 Bivalent Vaccine
11 Nov 2022 //
PRESS RELEASE
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5
10 Nov 2022 //
GLOBENEWSWIRE
UK approves Pfizer-BioNTech`s COVID booster targeting Omicron BA.4/5
09 Nov 2022 //
REUTERS
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
07 Nov 2022 //
GLOBENEWSWIRE
